ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis (RA) and risk assessment"

  • Abstract Number: 338 • 2018 ACR/ARHP Annual Meeting

    Implementation of an Automated Phrase to Increase Awareness of Cardiovascular Risk in Rheumatoid Arthritis Patients in an Urban Fellows Rheumatology Clinic

    Leslie Anne Cassidy1, Jennifer Brandt1, Alison Gizinski2, Arezou Khosroshahi1, Gaobin Bao1 and S. Sam Lim3, 1Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, 3Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Rheumatoid arthritis (RA) is a significant and well-established risk factor for atherosclerotic cardiovascular disease (ASCVD). Cardiovascular risk stratification is often left to the primary…
  • Abstract Number: 1861 • 2018 ACR/ARHP Annual Meeting

    Lipid Screening in Medicare Beneficiaries with Rheumatoid Arthritis

    Nikila Kumar1, Wei-Hsuan Lo-Ciganic2, Lili Zhou3,4, Erin L. Ashbeck4 and C. Kent Kwoh1,4, 1Division of Rheumatology, Department of Medicine, The University of Arizona, Tucson, AZ, 2Department of Pharmacy, Practice and Science, College of Pharmacy, University of Arizona, TUCSON, AZ, 3College of Pharmacy, University of Arizona, Tucson, AZ, 4University of Arizona Arthritis Center, Tucson, AZ

    Background/Purpose: Patients with RA have an increased risk of cardiovascular disease (CVD) accounting for over 50% of premature deaths in the RA population. EULAR recommends…
  • Abstract Number: 1862 • 2018 ACR/ARHP Annual Meeting

    Exploring the Lipid Paradox Theory in Rheumatoid Arthritis: Very Low Circulating Low-Density Lipoprotein Concentration Levels Are Associated with Pro-Atherogenic Biomarkers

    Jon T. Giles1, Cecilia P. Chung2, Mary Chester-Wasko3, Mike Centola4, Jenny Van Eyk5, Justyna Fert-Bober5, Amy Kao6, Annette M. Oeser7, C. Michael Stein2 and Joan Bathon8, 1Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 3Allegheny Health Network, Pittsburgh, PA, 4Haus Bioceuticals, Inc, Oklahoma City, OK, 5Cedars-Sinai Medical Center, Los Angeles, CA, 6Biogen, Cambridge, MA, 7Vanderbilt University Medical Center, Nashville, TN, 8Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY

    Background/Purpose: Rheumatoid arthritis (RA) patients with very low levels of circulating low density lipoprotein cholesterol (LDL-C) have been reported to be at particularly high risk…
  • Abstract Number: 2952 • 2018 ACR/ARHP Annual Meeting

    Major NSAID Toxicity: Derivation and Internal Validation of a Simple Clinical Risk Score

    Daniel Solomon1, Ming Shao2, Katherine E Wolski3, Steven E Nissen4, M. Elaine Husni5 and Nina Paynter6, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Cleveland Clinic Foundation, Cleveland, OH, 3Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, 4Cardiovascular Medicine, Chair, Cleveland Clinic, Cleveland, OH, 5Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 6Medicine, Harvard University, Boston, MA

    Background/Purpose: NSAIDs and Coxibs represent one of the most commonly prescribed drugs by rheumatologists and are used regularly by >10 million Americans. While most patients…
  • Abstract Number: 84 • 2018 ACR/ARHP Annual Meeting

    ACPA-Positive Risk-RA Subject without Subclinical Arthritis Are in High Risk for Later Arthritis Onset, Especially Carriers of HLA-SE Risk-Gene

    Aase Hensvold1,2, Yogan Kisten1,2, Monika Hansson1, Alexandra Cîrciumaru1, Meng Sun1, Hamed Rezaei3, Erik af Klint1, Guozhong Fei2, Aleksandra Antovic2 and Anca I. Catrina1,2, 1Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 2Stockholm Health Services, Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden, 3Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are predictive markers with pathological effects in rheumatoid arthritis (RA) development. Previous studies of ACPA-positive patients with musculoskeletal complaints (mainly…
  • Abstract Number: 200 • 2018 ACR/ARHP Annual Meeting

    Validation of the Ers-RA Risk Score in a Dutch Population

    Milad Baniaamam1 and Michael Nurmohamed2, 1Department of rheumatology, Amsterdam Rheumatology immunology Center | Reade and VU University Medical Center Amsterdam, Netherlands, Amsterdam, Netherlands, 2Rheumatology, VU University Medical Center, Amsterdam, Netherlands

     Background/Purpose: The most frequent cause of death in patients with chronic rheumatoid arthritis (RA) is of cardiovascular (CV) origin. CV risk prediction scores in the…
  • Abstract Number: 1863 • 2017 ACR/ARHP Annual Meeting

    Inflammatory Dietary Pattern and Risk of Developing Rheumatoid Arthritis in Women

    Bing Lu1, Jeffrey A. Sparks1, Susan Malspeis1, Medha Barbhaiya1, Sara K. Tedeschi2, Karen H. Costenbader3 and Elizabeth Karlson3, 1Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology and Allergy,, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: The preclinical period of rheumatoid arthritis (RA) is characterized by elevated inflammatory biomarkers but it is unclear whether inflammatory diet may contribute to RA…
  • Abstract Number: 2359 • 2017 ACR/ARHP Annual Meeting

    Severity of Ischemic and Hemorrhagic Stroke in Patients with Rheumatoid Arthritis Compared with the General Population

    Mei-Yun Hsieh1, Chang-Fu Kuo2, Kuang-Hui Yu2, Shue-Fen Luo2,3 and Yen-Fu Chen2, 1Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 2Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 3Chang Gung Memorial Hospital, Taoyuan, Taiwan

    Background/Purpose: Rheumatoid arthritis (RA) patients are at higher risk of developing stroke but whether their risks for severe strokes are unknown. Methods: All patients with…
  • Abstract Number: 548 • 2016 ACR/ARHP Annual Meeting

    Body Mass Index Is Positively Correlated with Diverse Disease Activity Measures in Longstanding Rheumatoid Arthritis

    Craig Wiesenhutter, Coeur d'Alene Arthritis Clinic, Coeur D Alene, ID; University of Washington School of Family Medicine, Seattle, ID

    Background/Purpose: Obesity is a common problem with patients who have rheumatoid arthritis (RA). Adipose tissue has been shown to produce cytokines that are proinflammatory. The…
  • Abstract Number: 1467 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: Non-Invasive Arterial Health Testing to Assess Subclinical Risk of Cardiovascular Disease

    Erin Scanlon1, Rekha Mankad2, Cynthia S. Crowson3, Iftikhar Kullo4, Sharon Mulvagh2, Eric L. Matteson1, Zoran Kvrgic1 and John M. Davis III5, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose:   Measures of arterial health may be useful in assessing the risk of atherosclerotic cardiovascular disease (ASCVD) in patients with rheumatoid arthritis (RA). The…
  • Abstract Number: 1469 • 2016 ACR/ARHP Annual Meeting

    Coronary Territories Are Not Affected in Mexican Mestizo Patients with Rheumatoid Arthritis in Comparison to Matched Controls: Evaluation Using Speckle Tracking Echocardiography

    Dionicio A. Galarza-Delgado1, Iris J. Colunga-Pedraza2,3,4, Jose Ramon Azpiri-Lopez5, Adrian Martinez-Moreno6, Rosa I. Arvizu-Rivera2, Raymundo Vera-Pineda7, Alberto Cardenas-de La Garza3, Mario Alberto Garza-Elizondo8, Mario Alberto Benavides-González6, Miguel A. Ramos-Guzman6, Luis E. Gonzalez-Carrillo6 and Filiberto Hervert-Cavazos6, 1Internal Medicine/Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, 2Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, 3Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 4Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 6Cardiology, Hospital Universitario UANL, Monterrey, Mexico, 7Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 8Rheumatology, Hospital Universitario UANL., Monterrey, N.L., Mexico

    Background/Purpose:  Atherosclerotic cardiovascular disease is the leading cause of death in patients with rheumatoid arthritis (RA). Two dimensional speckle tracking echocardiography (TSE) assess local and…
  • Abstract Number: 1519 • 2016 ACR/ARHP Annual Meeting

    How Much, and When, Does Autoimmune Thyroid Disease Increase the Risk of RA, and Does RA-Onset Impact the Risk of Autoimmune Thyroid Disease?

    Kristin Waldenlind1, Saedis Saevarsdottir1, Camilla Bengtsson2 and Johan Askling1, 1Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Environmental medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Autoimmune thyroid disease (AITD) is one of the most common autoimmune diseases, and occurs more often than expected in patients with Rheumatoid Arthritis (RA).…
  • Abstract Number: 545 • 2015 ACR/ARHP Annual Meeting

    Baseline Serum Soluble Interleukin–2 Receptor Alpha (sIL–2Rα) Levels Increased as Intervals Decreased from Cohort Entry to Onset of Incident Rheumatoid Arthritis (pre–RA), not Observed in Matched Control (CN) Subjects

    Alfonse T. Masi1, Azeem A. Rehman1, Jean C. Aldag1 and Huaping Wang2, 1Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, 2Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, IL

    Background/Purpose:  Baseline sIL-2Rα levels predicted total mortality in both pre-RA and matched CN subjects, in a preceding prospective cohort study (A&R 2010; 62:S19). Now, the…
  • Abstract Number: 911 • 2015 ACR/ARHP Annual Meeting

    Patients with Rheumatoid Arthritis Are at Increased Risk of Both Ischemic and Non-Ischemic Heart Failure

    Ängla Mantel1, Marie Holmqvist1, Daniel Andersson2,3, Lars Lund2,3 and Johan Askling4,5, 1Dept of Medicine, Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Department of medicine, Karolinska Institutet, Cardiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 3Karolinska university hospital, Cardiology Unit, Karolinska University Hospital, Stockholm, Sweden, 4Rheumatology Unit, Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, 5Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Studies among unselected patients with rheumatoid arthritis (RA) suggest increased risks of both ischemic and non-ischemic heart failure (HF). Since the risk of these…
  • Abstract Number: 1515 • 2015 ACR/ARHP Annual Meeting

    Accounting for Rheumatoid Arthritis in the Determination of 10 Year Cardiovascular Risk

    Rupal Chavda and Rochella A. Ostrowski, Rheumatology, Loyola University Medical Center, Maywood, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) carry a higher risk for cardiovascular disease (CVD) independent of traditional risk factors.  In this study, we set out…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology